Long-Term Safety and Efficacy of Two Different Antimuscarinics, Imidafenacin and Solifenacin, for Treatment of Overactive Bladder: A Prospective Randomized Controlled Study

By  

Urologia Internationalis, Vol. 90, Iss. 2, 2012-11 ,pp. : 161-167

Karger

Access to resources Recommend Favorite

Patient‐reported outcomes from SYNERGY, a randomized, double‐blind, multicenter study evaluating combinations of mirabegron and solifenacin compared with monotherapy and placebo in OAB patients

By  

NEUROUROLOGY AND URODYNAMICS, Vol. 37, Iss. 1, 2018-01 ,pp. : 394-406

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of fesoterodine 4 mg on bladder diary and patient-reported outcomes during the first week of treatment in subjects with overactive bladder

By Corcos Jacques   Angulo Javier C.   Garely Alan D.   Carlsson Martin   Gong Jason   Guan Zhonghong  

Current Medical Research and Opinion, Vol. 27, Iss. 5, 2011-05 ,pp. : 1059-1065

Informa Healthcare

Access to resources Recommend Favorite

Comparison of Therapeutic Efficacy and Urodynamic Findings of Solifenacin Succinate versus Mirabegron in Women with Overactive Bladder Syndrome: Results of a Randomized Controlled Study

By  

Urologia Internationalis, Vol. 97, Iss. 3, 2016-04 ,pp. : 325-329

Karger

Access to resources Recommend Favorite

Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence

By Rogers Rebecca G.   Bachmann Gloria   Scarpero Harriette   Jumadilova Zhanna   Sun Franklin   Morrow Jon D.   Guan Zhonghong   Bavendam Tamara  

Current Medical Research and Opinion, Vol. 25, Iss. 9, 2009-09 ,pp. : 2159-2165

Informa Healthcare

Access to resources Recommend Favorite